---
input_text: A case of adult-onset type II citrullinemia with comorbid epilepsy even
  after liver transplantation. The current study using single case voxel-based morphometry
  (VBM) of magnetic resonance imaging (MRI) and 1H-MR-spectroscopy (1H-MRS) explores
  the neural background of unexplained seizure attacks and electroencephalography
  (EEG) abnormalities persisting even after liver transplantation in a patient with
  adult-onset type II citrullinemia (CTLN2). Although the MRI had shown no gross abnormality,
  the VBM revealed significantly smaller-than-normal regional volume in the left hippocampus
  of the patient as compared with 111 age-matched controls. 1H-MRS further indicated
  reduction of all metabolite concentrations in the left hippocampus compared with
  those in the right homolog region, with the single exception of elevated glutamate
  concentration. These results are similar to those of patients with mesial temporal
  lobe epilepsy (TLE), although CTLN2-complicated mesial TLE has rarely been reported.
  In contrast to TLE, periictal asterixis and interictal slow activities on EEG support
  another possibility that the patient might have slight metabolic encephalopathy
  even after the liver transplantation.
raw_completion_output: |-
  primary_disease: adult-onset type II citrullinemia (CTLN2)

  medical_actions: liver transplantation; voxel-based morphometry (VBM); magnetic resonance imaging (MRI); 1H-MR-spectroscopy (1H-MRS); electroencephalography (EEG)

  symptoms: unexplained seizure attacks; EEG abnormalities; significantly smaller-than-normal regional volume in the left hippocampus; reduction of all metabolite concentrations in the left hippocampus; elevated glutamate concentration; periictal asterixis; interictal slow activities

  chemicals: glutamate

  action_annotation_relationships: liver transplantation TREATS adult-onset type II citrullinemia (CTLN2); VBM TREATS unexplained seizure attacks IN adult-onset type II citrullinemia (CTLN2); MRI TREATS unexplained seizure attacks IN adult-onset type II citrullinemia (CTLN2); 1H-MR-spectroscopy (1H-MRS) TREATS unexplained seizure attacks IN adult-onset type II citrullinemia (CTLN2); electroencephalography (EEG) TREATS EEG abnormalities IN adult-onset type II citrullinemia (CTLN2); voxel-based morphometry (VBM) TREATS significantly smaller-than-normal regional volume in the left hippocampus IN adult-onset type II citrullinemia (CTLN2); 1H-MR-spectroscopy (1H-MRS) TREATS reduction of all metabolite concentrations in the left hippocampus IN adult-onset type II citrullinemia (CTLN2); 1H-MR-spectroscopy (with glutamate) TREATS elevated glutamate concentration IN adult-onset type II citrullinemia (CTLN2)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  1H-MR-spectroscopy (with glutamate) TREATS elevated glutamate concentration IN adult-onset type II citrullinemia (CTLN2)

  ===

extracted_object:
  primary_disease: MONDO:0016603
  medical_actions:
    - MAXO:0001175
    - voxel-based morphometry (VBM)
    - magnetic resonance imaging (MRI)
    - 1H-MR-spectroscopy (1H-MRS)
    - MAXO:0000932
  symptoms:
    - unexplained seizure attacks
    - HP:0002353
    - significantly smaller-than-normal regional volume in the left hippocampus
    - reduction of all metabolite concentrations in the left hippocampus
    - elevated glutamate concentration
    - periictal asterixis
    - interictal slow activities
  chemicals:
    - CHEBI:29987
  action_annotation_relationships:
    - subject: MAXO:0001175
      predicate: TREATS
      object: adult-onset type II citrullinemia
      qualifier: MONDO:0016603
    - predicate: TREATS
      object: unexplained seizure attacks
      qualifier: MONDO:0016603
      subject_extension: VBM
    - subject: MRI
      predicate: TREATS
      object: unexplained seizure attacks
      qualifier: MONDO:0016603
      subject_extension: MRI
    - subject: 1H-MR-spectroscopy
      predicate: TREATS
      object: unexplained seizure attacks
      qualifier: MONDO:0016603
      subject_extension: 1H-MR-spectroscopy
    - subject: MAXO:0000932
      predicate: TREATS
      object: HP:0002353
      qualifier: MONDO:0016603
    - subject: voxel-based morphometry (VBM)
      predicate: TREATS
      object: significantly smaller-than-normal regional volume in the left hippocampus
      qualifier: MONDO:0016603
      subject_extension: voxel-based morphometry (VBM)
    - subject: 1H-MR-spectroscopy (1H-MRS)
      predicate: TREATS
      object: reduction of all metabolite concentrations in the left hippocampus
      qualifier: MONDO:0016603
      subject_extension: 1H-MR-spectroscopy (1H-MRS)
    - subject: 1H-MR-spectroscopy
      predicate: TREATS
      object: elevated glutamate concentration
      qualifier: MONDO:0016603
      subject_qualifier: with glutamate
      subject_extension: CHEBI:29987
named_entities:
  - id: MONDO:0019052
    label: Inborn errors of metabolism (IEMs)
  - id: MAXO:0001175
    label: Liver transplantation
  - id: MONDO:0016603
    label: Adult-onset citrullinemia (CTLN2)
  - id: MONDO:0016602
    label: citrin deficiency
  - id: MONDO:0008988
    label: Citrullinemia type 1
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: MAXO:0000127
    label: Genetic analysis
  - id: MAXO:0000376
    label: Liver biopsy
  - id: HP:0001987
    label: Hyperammonemia
  - id: CHEBI:22918
    label: Branched-chain amino acids (BCAA)
  - id: MONDO:0015991
    label: Citrullinemia
  - id: MAXO:0000602
    label: Hemodialysis
  - id: CHEBI:16150
    label: Benzoate
  - id: HP:0001945
    label: fever
  - id: HP:0003270
    label: abdominal distention
  - id: HP:0002155
    label: hypertriglyceridemia
  - id: MAXO:0001298
    label: therapy
  - id: MONDO:0009563
    label: maple syrup urine disease (MSUD)
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: HP:0000952
    label: Jaundice
  - id: HP:0001289
    label: Confusion
  - id: CHEBI:46195
    label: Acetaminophen
  - id: HP:0006554
    label: Acute liver failure
  - id: HP:0001943
    label: hypoglycemia
  - id: HP:0001397
    label: fatty liver
  - id: HP:0003388
    label: easy fatigability
  - id: HP:0001824
    label: weight loss
  - id: HP:0001508
    label: failure to thrive
  - id: HP:0003119
    label: dyslipidemia
  - id: CHEBI:16374
    label: vitamin K2
  - id: CHEBI:9907
    label: ursodeoxycholic acid
  - id: CHEBI:50144
    label: sodium pyruvate
  - id: CHEBI:17754
    label: glycerol
  - id: CHEBI:28757
    label: fructose
  - id: CHEBI:30879
    label: alcohol
  - id: HP:0001250
    label: seizures
  - id: HP:0006846
    label: acute encephalopathy
  - id: HP:0002480
    label: Hepatic encephalopathy
  - id: MONDO:0020579
    label: Mucositis
  - id: HP:0031864
    label: bacteremia
  - id: CHEBI:28876
    label: melphalan
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: HP:0001410
    label: hepatopathy
  - id: MONDO:0004739
    label: Urea Cycle Disorders (UCDs)
  - id: CHEBI:16349
    label: L-citrulline
  - id: CHEBI:29016
    label: Arginine
  - id: HP:0000708
    label: abnormal behaviors
  - id: HP:0001263
    label: Cognitive delay
  - id: MONDO:0011601
    label: NICCD (neonatal intrahepatic cholestasis caused by citrin deficiency)
  - id: HP:0001396
    label: Cholestasis
  - id: HP:0003256
    label: Coagulopathy
  - id: MAXO:0000932
    label: EEG
  - id: MAXO:0000468
    label: peritoneal lavage
  - id: HP:0002045
    label: hypothermia
  - id: CHEBI:33363
    label: PD
  - id: MONDO:0004789
    label: Cholangitis
  - id: CHEBI:16467
    label: L-arginine
  - id: HP:0001406
    label: Intrahepatic cholestasis
  - id: HP:0012023
    label: Galactosuria
  - id: CHEBI:36080
    label: Protein
  - id: CHEBI:17716
    label: Lactose
  - id: CHEBI:16646
    label: Carbohydrate
  - id: CHEBI:18211
    label: Citrulline
  - id: CHEBI:18186
    label: Tyrosine
  - id: CHEBI:16811
    label: Methionine
  - id: CHEBI:26986
    label: Threonine
  - id: CHEBI:4466
    label: Precedex (dexmedetomidine)
  - id: CHEBI:9130
    label: Sevoflurane
  - id: HP:0012531
    label: pain
  - id: CHEBI:35482
    label: narcotics
  - id: HP:0011968
    label: Poor feeding
  - id: HP:0001298
    label: Encephalopathy
  - id: HP:0008162
    label: Asymptomatic hyperammonemia
  - id: MONDO:0015183
    label: Short bowel syndrome
  - id: CHEBI:18050
    label: L-glutamine
  - id: HP:0002586
    label: Peritonitis
  - id: HP:0003774
    label: Chronic renal failure
  - id: HP:0001919
    label: acute renal failure
  - id: MONDO:0006663
    label: perinatal asphyxia
  - id: MONDO:0018477
    label: kernicterus
  - id: HP:0001249
    label: Mental retardation
  - id: HP:0001510
    label: Growth deficiency
  - id: HP:0001639
    label: Hypertrophic cardiomyopathy
  - id: HP:0000518
    label: Cataracts
  - id: HP:0002133
    label: Status epilepticus
  - id: HP:0001259
    label: Coma
  - id: HP:0003128
    label: Lactic acidosis
  - id: HP:0002181
    label: Brain edema
  - id: HP:0002353
    label: EEG abnormalities
  - id: CHEBI:29987
    label: glutamate
